In two previous studies, we showed that women who were immunopositive for p53 in normal or benign breast tissue had a 2- to 2.5-fold increased risk of developing subsequent invasive breast cancer [30, 31]. This evidence concerns the gene TP53 and invasive breast carcinoma.